Sudhakar Pandiyan - Alembic Pharmaceuticals Head Operations
| APLLTD Stock | 881.25 5.90 0.67% |
Executive
Sudhakar Pandiyan is Head Operations of Alembic Pharmaceuticals Limited
| Address | Alembic Road, Vadodara, India, 390003 |
| Phone | 91 26 5663 7000 |
| Web | https://alembicpharmaceuticals.com |
Alembic Pharmaceuticals Management Efficiency
The company has return on total asset (ROA) of 0.0661 % which means that it generated a profit of $0.0661 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1381 %, meaning that it generated $0.1381 on every $100 dollars invested by stockholders. Alembic Pharmaceuticals' management efficiency ratios could be used to measure how well Alembic Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. At present, Alembic Pharmaceuticals' Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 3.6 B, whereas Total Assets are forecasted to decline to about 40.9 B.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Kamal Kant | LLOYDS METALS AND | 65 | |
| Narayan Mitra | Indian Metals Ferro | N/A | |
| Gunjan Jain | Univa Foods Limited | N/A | |
| Ravindra Shukla | LLOYDS METALS AND | 56 | |
| Akshay Vora | LLOYDS METALS AND | N/A | |
| Somya Kasliwal | Univa Foods Limited | N/A | |
| S Raghavendran | Consolidated Construction Conso | 59 | |
| Rajesh Chawla | Varun Beverages Limited | N/A | |
| Yashesh Parekh | Man Infraconstruction Limited | N/A | |
| Pramod Gupta | LLOYDS METALS AND | 63 | |
| Rama Satapathy | LLOYDS METALS AND | 58 | |
| X Anandan | Consolidated Construction Conso | 64 | |
| Dinesh Patidar | LLOYDS METALS AND | 62 | |
| Smruti Ray | Indian Metals Ferro | N/A | |
| M Murugesan | LLOYDS METALS AND | 50 | |
| T Bhaskar | LLOYDS METALS AND | 63 | |
| J Mohamed | Consolidated Construction Conso | 45 | |
| Rajeshwar Tripathi | Varun Beverages Limited | N/A | |
| Sandeep Narade | Indian Metals Ferro | N/A | |
| Rohit Gupta | Varun Beverages Limited | N/A | |
| Swaminathan Chama | Consolidated Construction Conso | 71 | |
Management Performance
| Return On Equity | 0.14 | ||||
| Return On Asset | 0.0661 |
Alembic Pharmaceuticals Leadership Team
Elected by the shareholders, the Alembic Pharmaceuticals' board of directors comprises two types of representatives: Alembic Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Alembic. The board's role is to monitor Alembic Pharmaceuticals' management team and ensure that shareholders' interests are well served. Alembic Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Alembic Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Charandeep Saluja, Company Officer | ||
| Dr S, Chief Officer | ||
| Udit Amin, Chief Officer | ||
| Chandrahas Shetty, Senior Resources | ||
| Raj Baheti, CFO Finance | ||
| Manisha Saraf, Company Officer | ||
| Chirayu Amin, Executive CEO | ||
| Shaunak Amin, MD Director | ||
| Ajay Desai, Senior Finance | ||
| Gautam Chatterjee, Senior President | ||
| Nilesh Wadhwa, Head Strategy | ||
| Vinod Kamath, President Operations | ||
| Pranav Amin, Managing Director | ||
| Sudhakar Pandiyan, Head Operations |
Alembic Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Alembic Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.14 | ||||
| Return On Asset | 0.0661 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 183.9 B | ||||
| Shares Outstanding | 196.56 M | ||||
| Shares Owned By Insiders | 70.82 % | ||||
| Shares Owned By Institutions | 15.96 % | ||||
| Price To Book | 3.57 X | ||||
| Price To Sales | 2.70 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Other Information on Investing in Alembic Stock
Alembic Pharmaceuticals financial ratios help investors to determine whether Alembic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alembic with respect to the benefits of owning Alembic Pharmaceuticals security.